Annarosa Arcangeli

A HERG current sustains a cardiac-type action potential in neuroblastoma S cells.

hERG1 channels in human esophagus: evidence for their aberrant expression in the malignant progression of Barrett's esophagus.

Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells.

hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer.

Integrin structure and functional relation with ion channels.

Optical methods in the study of protein-protein interactions.

Physical and functional interaction between integrins and hERG1 channels in cancer cells.

Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway.

Deterministic and stochastic aspects of VEGF-A production and the cooperative behavior of tumoral cell colony.

hERG1 Channels and Glut-1 as Independent Prognostic Indicators of Worse Outcome in Stage I and II Colorectal Cancer: A Pilot Study.

Immunohistochemical biomarkers in gastric cancer research and management.

High hERG1 expression in advanced melanoma.

Advances in lipid-based platforms for RNAi therapeutics.

An analytical method for the quantification of hERG1 channel gene expression in human colorectal cancer.

hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer.

Over-Expression of the LH Receptor Increases Distant Metastases in an Endometrial Cancer Mouse Model.

Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO nanoparticles for targeting pancreatic ductal adenocarcinoma cells.

Searching for protein binding sites from Molecular Dynamics simulations and paramagnetic fragment-based NMR studies.

Characterization of hERG1 channel role in mouse colorectal carcinogenesis.

hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications.

Interaction of tumour cells with their microenvironment: ion channels and cell adhesion molecules. A focus on pancreatic cancer.

Time resolved SAXS to study the complexation of siRNA with cationic micelles of divalent surfactants.

VEGF-A clinical significance in gastric cancers: immunohistochemical analysis of a wide Italian cohort.

NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels.

New pyrimido-indole compound CD-160130 preferentially inhibits the KV11.1B isoform and produces antileukemic effects without cardiotoxicity.

Ion channel expression as promising cancer biomarker.

Lymphatic endothelial progenitor cells and vascular endothelial growth factor-C in spondyloarthritis and Crohn's disease: two overlapping diseases?

Design, synthesis and characterisation of new chimeric ruthenium(II)-gold(I) complexes as improved cytotoxic agents.

Novel perspectives in cancer therapy: Targeting ion channels.

cis-Pt I2(NH3)2: a reappraisal.

hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers.

Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug.

Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles.

hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance.

LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer.

New Trends in Cancer Therapy: Targeting Ion Channels and Transporters.

hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy.

hERG Channels: From Antitargets to Novel Targets for Cancer Therapy.

The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression.

A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: comparison with in vitro cultures and in vivo xenografts.

Auranofin, EtPAuCl, and EtPAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study.

Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients' Age and Disease Duration.

The combined activation of K3.1 and inhibition of K11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells.

Engineering l-asparaginase for spontaneous formation of calcium phosphate bioinspired microreactors.

Postnatal Changes in K/Cl Cotransporter-2 Expression in the Forebrain of Mice Bearing a Mutant Nicotinic Subunit Linked to Sleep-Related Epilepsy.

hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer.

Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow‑induced chemoresistance in acute leukemias.

Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging.

Ion Channel Conformations Regulate Integrin-Dependent Signaling.

The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Adenocarcinoma Cells.

Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer.

The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma.

Data describing the effects of the Macrolide Antibiotic Clarithromycin on preclinical mouse models of Colorectal Cancer.

Ion Channel Targeting with Antibodies and Antibody Fragments for Cancer Diagnosis.

hERG1 and CA IX expression are associated with disease recurrence in surgically resected clear cell renal carcinoma.

The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples.

hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients.

Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K.

Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H, K-ATPases in Pancreatic Cancer and Stellate Cells.

Correction: Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K.

K11.1 Potassium Channel and the Na/H Antiporter NHE1 Modulate Adhesion-Dependent Intracellular pH in Colorectal Cancer Cells.

Analysis of resorbable mesh implants in short-term human muscular fascia cultures: a pilot study.

and mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation.

Data describing the effects of potassium channels modulators on outward currents measured in human lymphoma cell lines.

Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma.

Expression and purification of a novel single-chain diabody (scDb-hERG1/β1) from Pichia pastoris transformants.

Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy.

Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses.

Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells.

Harnessing the hERG1/β1 Integrin Complex via a Novel Bispecific Single-chain Antibody: An Effective Strategy against Solid Cancers.

Neonatal Nav1.5 Protein Expression in Human Colorectal Cancer: Immunohistochemical Characterization and Clinical Evaluation.

A Transcriptomic Approach Reveals Selective Ribosomal Remodelling in the Tumour Versus the Stromal Compartment of Metastatic Colorectal Cancer.

Bioelectricity of Cancer.

Circulating miRNome profiling data in Behçet's syndrome.